Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stein

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
Cancer Management and Research|June 14, 2019
Impact of taste and smell training on taste disorders during chemotherapy - TASTE trialJulia von Grundherr, Barbara Koch, Donata Grimm, et al.
Science (New York, N.Y.)|June 2, 2012
Membrane fusion intermediates via directional and full assembly of the SNARE complexJavier M Hernandez, Alexander Stein, Elmar Behrmann, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 13, 2014
A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancerCarsten Bokemeyer, Alexander Stein, Karsten Ridwelski, et al.
Molecular Biology of the Cell|December 21, 2007
A novel site of action for alpha-SNAP in the SNARE conformational cycle controlling membrane fusionMarcin Barszczewski, John J Chua, Alexander Stein, et al.
Cancer Letters|September 6, 2020
Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-raysKai Rothkamm, Sabrina Christiansen, Thorsten Rieckmann, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trialLisa Paschold, Alexander Stein, Benjamin Thiele, et al.
Onkologie|August 8, 2013
Cancer patients and advance directives: a survey of patients in a hematology and oncology outpatient clinicElisabeth Hubert, Nadine Schulte, Sebastian Belle, et al.
The EMBO Journal|November 12, 2024
Determinants of chemoselectivity in ubiquitination by the J2 family of ubiquitin-conjugating enzymesAnuruti Swarnkar, Florian Leidner, Ashok K Rout, et al.
BMC Cancer|October 5, 2013
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trialAlexander Stein, Albrecht Kretzschmar, Dirk Behringer, et al.
Zeitschrift Fur Gastroenterologie|February 5, 2020
Current status of immunotherapy in gastrointestinal malignanciesSylvie Lorenzen, Florian Lordick, Sven Heiko Loosen, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Cancer Management and Research|June 14, 2019
Impact of taste and smell training on taste disorders during chemotherapy - TASTE trialJulia von Grundherr, Barbara Koch, Donata Grimm, et al.
Science (New York, N.Y.)|June 2, 2012
Membrane fusion intermediates via directional and full assembly of the SNARE complexJavier M Hernandez, Alexander Stein, Elmar Behrmann, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 13, 2014
A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancerCarsten Bokemeyer, Alexander Stein, Karsten Ridwelski, et al.
Molecular Biology of the Cell|December 21, 2007
A novel site of action for alpha-SNAP in the SNARE conformational cycle controlling membrane fusionMarcin Barszczewski, John J Chua, Alexander Stein, et al.
Cancer Letters|September 6, 2020
Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-raysKai Rothkamm, Sabrina Christiansen, Thorsten Rieckmann, et al.
Journal for Immunotherapy of Cancer|June 16, 2023
First-line treatment of unresectable or metastatic HER2 positive esophagogastric adenocarcinoma: liquid biomarker analysis of the phase 2 INTEGA trialLisa Paschold, Alexander Stein, Benjamin Thiele, et al.
Onkologie|August 8, 2013
Cancer patients and advance directives: a survey of patients in a hematology and oncology outpatient clinicElisabeth Hubert, Nadine Schulte, Sebastian Belle, et al.
The EMBO Journal|November 12, 2024
Determinants of chemoselectivity in ubiquitination by the J2 family of ubiquitin-conjugating enzymesAnuruti Swarnkar, Florian Leidner, Ashok K Rout, et al.
BMC Cancer|October 5, 2013
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trialAlexander Stein, Albrecht Kretzschmar, Dirk Behringer, et al.
Zeitschrift Fur Gastroenterologie|February 5, 2020
Current status of immunotherapy in gastrointestinal malignanciesSylvie Lorenzen, Florian Lordick, Sven Heiko Loosen, et al.
Pageof 15